Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aspen Pharmacare Holdings Ltd To Acquire Drugs And Plant-Reuters


Thursday, 27 Jun 2013 06:55am EDT 

Reuters reported that Aspen Pharmacare Holdings Ltd said that it would acquire drugs and a plant from U.S. firm Merck in a $1 billion deal that bolsters its presence in Europe, Latin America and Asia. The African generic drugs maker said it would buy an active pharmaceutical ingredient (API) business located in the Netherlands and a portfolio of 11 drug brands from Merck. 

Company Quote

40383.07
631.0 +1.59%
19 Dec 2014